Severe anaphylactoid shock secondary to gadolinium contrast media

Annals of Allergy, Asthma and Immunology

Volumn 103, Issue 4, 2009, Pages 359-360

  Simons, Caroline Watson ^a   Benouni, Saraleen ^a   Gibbon, Gary ^a   Klaustermeyer, William ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; GADOTERIDOL; HETEROCYCLIC COMPOUND; ORGANOMETALLIC COMPOUND;

ANAPHYLAXIS; CHEMICALLY INDUCED DISORDER; FEMALE; HUMAN; IMMUNOLOGY; LETTER; MIDDLE AGED;

ANAPHYLAXIS; CONTRAST MEDIA; FEMALE; HETEROCYCLIC COMPOUNDS; HUMANS; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS;

EID: 79953004671     PISSN: 10811206     EISSN: 15344436     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)60541-8     Document Type: Letter

References (8)

1. Murphy KJ, Brunberg JA, Cohan RH. Adverse reactions to gadolinium contrast media: a review of 36 cases. AJR Am J Roentgenol. 1996;167:847-849.
2. Li A, Wong CS, Wong MK, Lee CM, Au Yeung MC. Acute adverse reactions to magnetic resonance contrast media: gadolinium chelates. Br J Radiol. 2006;79: 368-371.
3. Runge VM. Safety of approved MR contrast media for intravenous injection. J Magn Reson Imaging. 2000;12:205-213.
4. Kirchin MA, Runge VM. Contrast agents for magnetic resonance imaging: safety update. Top Magn Reson Imaging. 2003;14:426-435.
5. Hasdenteufel F, Luyasu S, Renaudin J, et al. Anaphylactic shock after first exposure to gadoterate meglumine: two case reports documented by positive allergy assessment. J Allergy Clin Immunol. 2008;121:527-528.
6. Hasdenteufel F, Luyasu S, Renaudin J, et al. Reply. J Allergy Clin Immunol. 2008;122:216-217.
7. Beaudouin E, Kanny G, Blanloeil Y, Guilloux L, Renaudin JM, Moneret-Vautrin DA. Anaphylactic shock induced by gadoterate meglumine (DOTAREM). Allerg Immunol (Paris). 2003;35:382-385.
8. Kalogeromitros D, Makris M, Aggelides X, et al. Anaphylaxis to gadobenate dimeglumine (Multihance): a case report. Int Arch Allergy Immunol. 2007;144:150-154.